AI-based Clinical Trials Solution Provider Market Growth – at a CAGR of 21.5% During Forecast Period 2020-2028

Rapid adoption of AI-based clinical trial solutions by pharmaceutical and biotechnological companies and rise in drug research & development projects are some key factors driving market revenue growth

According to Emergen Research, the global AI-based clinical trials solution provider market size was USD 1.24 billion in 2020 and is expected to reach USD 5.86 billion in 2028 and register a revenue CAGR of 21.5% during the forecast period, 2021-2028.

Market Dynamics:

Revenue growth of the global AI-based clinical trials solution provider market is primarily attributed to factors such as rising prevalence of chronic and acute diseases worldwide, rise in new drug research & development projects, increasing adoption of AI-based clinical trial solutions by pharmaceutical and biotechnological companies to reduce clinical trial errors and operational costs, and rising awareness of the advantages of using these solutions.

Click Here to Access Free sample PDF Copy of the Report@

Artificial intelligence technology is rapidly emerging as a critical tool for advancing the healthcare sector. AI-based clinical trial solutions help reduce chances of errors in clinical trials, enhance operational efficiency, accelerate new drug discovery & development, and decrease costs. AI-powered data integration and pattern recognition solutions help in gathering and analyzing high volumes of data. Moreover, AI-based wearable technology is used in real-time, individualized patient monitoring during clinical trials to ensure patient compliance with specific protocols. Rising number of clinical research and studies, increasing government and private investments in healthcare infrastructure development, and introduction of novel AI-based technologies in the healthcare sector are other important factors driving the global market revenue growth.

COVID-19 Impact Analysis:

  • Social distancing and restrictions severely disrupted businesses and operations
  • Lockdowns caused disruptions in transportation and logistics
  • Impacted manufacturing activities and mining operations globally
  • Took a toll on economy of various countries
  • Caused sudden and drastic downturn in economic activity
  • Disrupted agriculture, fisheries, dairy, and other sectors
  • Caused loss of employment and financial crisis
  • Supply impacts were further compounded owing to reduced disposable income
  • Emergence of variants  continue to cause concerns and impact normal routines

Neurological Disease Segment Accounted for Largest Revenue Share in 2020:

The neurological disease segment dominated other segments in terms of revenue share in the global market in 2020. Rising prevalence of various neurological disorders such as Parkinson’s disease, Alzheimer’s disease, and epilepsy, and large-scale application of machine learning and deep learning platforms in clinical trials for predictive analysis and early diagnosis of various neurological conditions are among the key factors supporting revenue growth of this segment.

Looking for Discount [Click on the link] @

Contract Research Organizations (CROs) Segment to Account for Fastest Revenue CAGR:

The contract research organizations (CROs) segment is expected to register the fastest revenue growth rate in the global market over the forecast period. Growing demand for AI-based clinical trial solutions to streamline and accelerate clinical trial processes, and increasing outsourcing of clinical trial solutions by CROs to minimize drug development costs and improve drug safety and efficacy are major factors contributing to revenue growth of this segment.

North America Accounted for Largest Revenue Share in 2020:

Among regional markets, the North America AI-based clinical trials solution provider market accounted for the largest revenue share in the global market in 2020. Rapid integration of emerging technologies such as AI, machine learning, and deep learning in clinical trials, increasing number of clinical trials and studies, and rising focus on improving the operational efficiency and outcomes of clinical trials are some factors expected to drive market revenue of the market in the region. In addition, rise in public and private investments in the pharmaceutical and biopharmaceutical sectors and presence of key market players in the region, including IBM, AiCure, LLC, and BioAge Labs Inc., are some others key factors expected to contribute to the regional market revenue growth.

Major Companies in the Global AI-based Clinical Trials Solution Provider Market Include:

  • AiCure, LLC
  • AI, Inc.
  • BioAge Labs Inc.
  • Antidote Technologies, Inc.
  • Saama Technologies Inc.
  • International Machine Business Corporation (IBM)
  • Concentro Health AI
  • Deep 6 AI Inc.
  • PathAI Inc.
  • Owkin Inc.

Have a look at Report Description and Table of Contents of Market Report@

For the purpose of this report, Emergen Research has segmented the global AI-based clinical trials solution provider market based on clinical trial phase, therapeutic application, end-use, and region:

Clinical Trial Phase Outlook (Revenue, USD Billion; 2018–2028)

  • Phase-I
  • Phase-II
  • Phase-III

Therapeutic Application Outlook (Revenue, USD Billion; 2018–2028)

  • Cancer
  • Cardiovascular Disease
  • Neurological Disease
  • Metabolic Disease
  • Infectious Disease
  • Others

End-use Outlook (Revenue, USD Billion; 2018–2028)

  • Pharmaceutical Companies
  • Academic Research Institutions
  • Contract Research Organizations (CROs)
  • Others

Region Outlook (Revenue, USD Billion; 2018-2028)

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Saudi Arabia
    • U.A.E.
    • South Africa
    • Turkey
    • Rest of Middle East & Africa

Latest Published Reports by Emergen Research:

Insurance Market Size, Share, Trends, By Insurance Type (Life Insurance, Property Insurance, Health Insurance, Liability Insurance, Fire Insurance, Motor Insurance, Social Insurance), By Service Providers, By End-use, By Sales Channel, and By Region Forecast to 2028

Geospatial Analytics Market By Component (Services, and Solutions), By Solution (Geocoding and Reverse Geocoding, Data Integration and ETL, Reporting and Visualization, Thematic Mapping and Spatial Analysis, Others), By Application (Surveying, Medicine and Public Safety, Disaster Risk Reduction and Management, Climate Change Adaptation, Others), By Deployment type (On-Premise, Cloud), and By Region Forecast to 2028

Product Information Management Market By Offering (Services, Solution), By Deployment (On-premises, Cloud), By End-use (Media & Entertainment, BFSI, Healthcare, Retail, Transportation and Logistics), and By Region Forecast to 2028

IoT Connectivity Market By Component (Platform, Services) By Enterprise Size (Large Enterprise, Small and Medium Enterprise), By Application (Building & Home Automation, Smart Energy & Utility, Smart Manufacturing, Smart Grid, Smart Retail, Smart Transportation and Others) End Use (Education and Healthcare, Defense &Aerospace, IT & Telecommunication, Retail & E-commerce, Manufacturing, Others) and By Region Forecast to 2028

Blockchain Technology - Expanding Scope of the Disruptive Technology beyond Bitcoin

Top 10 Globally Leading Companies in the Email Encryption Market

Top 10 Prominent Companies in the World Offering Big Data as a Service

About Emergen Research

Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

Contact Us:

Eric Lee

Corporate Sales Specialist

Emergen Research | Web:

Direct Line: +1 (604) 757-9756


Visit for More Insights:

Explore Our Custom Intelligence services | Growth Consulting Services

Read Our Press release@




















Back to news